NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Singularity AMC Exits Jaro Institute of Technology Management and Research

Singularity AMC, a veteran investor-backed firm founded by Yash Kela, has exited Jaro Institute of Technology Management and Research by selling its entire 1.27 percent shareholding through open market transactions on May 19. The company's Singularity Growth Opportunities Fund II sold 2.8 lakh shares (1.27 percent stake) in the edtech and online higher education company for Rs 14.08 crore, with each share priced at Rs 501.33.

Singularity AMC had been an investor in Jaro Education since September 2025. However, the company's promoter, Sanjay Namdeo Salunkhe, has acquired some of the shares sold by Singularity AMC, buying 2.09 lakh shares (0.94 percent stake) for Rs 10.5 crore at Rs 503.91 per share. This marks the promoter's additional buying in the company since last week, bringing his current stake to 2.65 percent. As of March 2026, the promoters' shareholding in Jaro Education stood at 57.28 percent.

The stock market may have reacted to the deal, with Jaro Education shares rallying 6.17 percent to Rs 510.80 on the National Stock Exchange amid high volumes. The company's stock has been in an uptrend after bottoming out last week.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

CompanyShareholdingStake SoldSelling Price
Jaro Institute of Technology Management and Research1.27%2.8 lakhRs 501.33
Jaro Education---

Other Market Developments

Indian Emulsifiers shares were also in focus, hitting a record low of Rs 50.50 on the National Stock Exchange before ending at a new closing high of Rs 51.05, down 18.19 percent amid high volumes. This was after Prudent Equity, a portfolio management and equity research firm founded by Siddharth Oberoi, sold 1 lakh shares (0.54 percent stake) in the speciality chemicals maker for Rs 51.89 lakh at Rs 51.89 per share.

RFBL Flexi Pack, the printed multilayer flexible packaging materials manufacturer, saw significant action on its listing day, rallying 10.2 percent to finish at Rs 55.1 on the NSE Emerge. This may be attributed to 21.8 percent shares buying by several investors, including Jagid Vanitaben Rajendraprasad, L7 Securities, Smital Suresh Thakkar, Rathod Digvijaysinh Rajendrasinh, Riddhi Siddhi International, and Craft Emerging Market Fund PCC - Citadel Capital Fund, who bought 50.82 lakh shares (21.79 percent stake) in RFBL for Rs 26.71 crore.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Nexus Global Opportunities Fund has also made additional purchases in Choksi Laboratories, buying 68,727 equity shares (0.98 percent stake) for Rs 70.82 lakh at Rs 103.05 per share. The fund already held 6.03 percent stake in the company as of March 2026. However, CSG Financial & Management Services has exited Choksi Laboratories by selling its entire 70,000 shares (1 percent stake) for Rs 72.14 lakh at Rs 103.06 per share. The stock price soared 8.18 percent to Rs 107.1 on Tuesday.

Investor Takeaway

Investors should be aware of the changes in shareholding and potential impact on the company's stock price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.